This article was posted on the Pancreatic Cancer Action Network on March 9, 2018 by Allison Rosenweig, PhD. KRAS protein structure, reproduced with permission from NCI, FNLCR About 95 percent of pancreatic cancer cases – and around 30 percent of all human cancers – have a mutation in a gene called RAS. The resulting mutated … Continue reading NPR Focuses on One of the Biggest Challenges in Pancreatic Cancer: KRAS
Channing Der Serves as Thesis Opponent
Dr. Channing Der served as a thesis opponent to Arafath Kaja Najumudeen today at the Abo Akademi University in Turku, Finland. Arafath completed his PhD studies on the Ras oncogene.
Der Lab 